VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Stock Fundamental Analysis

TSX-V:VPT • CA92281P2008

0.105 CAD
0 (0%)
Last: Feb 26, 2026, 07:00 PM
Fundamental Rating

1

Overall VPT gets a fundamental rating of 1 out of 10. We evaluated VPT against 16 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VPT have multiple concerns. VPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year VPT has reported negative net income.
  • In the past year VPT has reported a negative cash flow from operations.
  • VPT had negative earnings in each of the past 5 years.
  • In the past 5 years VPT always reported negative operating cash flow.
VPT.CA Yearly Net Income VS EBIT VS OCF VS FCFVPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • The Return On Assets of VPT (-1076.66%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROIC N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPT.CA Yearly ROA, ROE, ROICVPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • VPT has a Gross Margin (54.21%) which is comparable to the rest of the industry.
  • VPT's Gross Margin has improved in the last couple of years.
  • VPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
VPT.CA Yearly Profit, Operating, Gross MarginsVPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

  • VPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VPT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VPT has been increased compared to 5 years ago.
  • VPT has a worse debt/assets ratio than last year.
VPT.CA Yearly Shares OutstandingVPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VPT.CA Yearly Total Debt VS Total AssetsVPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • VPT has an Altman-Z score of -272.50. This is a bad value and indicates that VPT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -272.50, VPT is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -272.5
ROIC/WACCN/A
WACC9.12%
VPT.CA Yearly LT Debt VS Equity VS FCFVPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that VPT may have some problems paying its short term obligations.
  • With a Current ratio value of 0.05, VPT is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.05 indicates that VPT may have some problems paying its short term obligations.
  • VPT's Quick ratio of 0.05 is on the low side compared to the rest of the industry. VPT is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
VPT.CA Yearly Current Assets VS Current LiabilitesVPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 23.15% over the past year.
  • The Revenue has grown by 28.55% in the past year. This is a very strong growth!
  • Measured over the past years, VPT shows a small growth in Revenue. The Revenue has been growing by 3.28% on average per year.
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPT.CA Yearly Revenue VS EstimatesVPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 50K 100K 150K 200K 250K

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VPT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VPT.CA Price Earnings VS Forward Price EarningsVPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPT.CA Per share dataVPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0.01 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for VPT!.
Industry RankSector Rank
Dividend Yield 0%

VENTRIPOINT DIAGNOSTICS LTD

TSX-V:VPT (2/26/2026, 7:00:00 PM)

0.105

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-28
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.05%
Ins Owner ChangeN/A
Market Cap19.57M
Revenue(TTM)175.60K
Net Income(TTM)-4.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 111.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1076.66%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.21%
FCFM N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -272.5
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%61.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.54%
OCF growth 3YN/A
OCF growth 5YN/A

VENTRIPOINT DIAGNOSTICS LTD / VPT.CA FAQ

What is the ChartMill fundamental rating of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA.


What is the valuation status of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to VENTRIPOINT DIAGNOSTICS LTD (VPT.CA). This can be considered as Overvalued.


What is the profitability of VPT stock?

VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) has a profitability rating of 1 / 10.


What is the financial health of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) stock?

The financial health rating of VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) is 0 / 10.